Clinical evaluation of the Triage® analytical device for drugs-of- abuse testing

Clinical Chemistry

Volumn 42, Issue 9, 1996, Pages 1433-1438

  De La Torre, Rafael ^a,c   Domingo Salvany, Antonia ^a   Badia, Roser ^a   Gonzàlez, Gerard ^a   Mcfarlane, Dave ^a   San, Luis ^b   Torrens, Marta ^b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c LMLM   (Spain)

Author keywords

abused drugs; benzodiazepines; drug testing; emergency analyses; fluorescence polarization immunoassay; toxicology

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABINOID; COCAINE; OPIATE DERIVATIVE;

ANALYTICAL EQUIPMENT; ARTICLE; DRUG ABUSE; DRUG DETERMINATION; DRUG SCREENING; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; URINALYSIS;

EID: 0029739043     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.9.1433     Document Type: Article

References (10)

1. Buechler KF, Moi S, Noar B, McGrath D, Vilella J, Clancy M, et al. Simultaneous detection of seven drugs of abuse by the Triage™ panel for drugs of abuse. Clin Chem 1992;38:1678-84.
2. Wu AHB, Wong SS, Johnson KG, Callies J, Shu DX, Dunn WE, Wong SHY. Evaluation of the Triage® system for emergency drugs-of-abuse testing in urine. J Anal Toxicol 1993;17:241-5.
3. de la Torre R, Ortuño J, González ML, Farré M, Camí J, Segura J. Determination of cocaine and its metabolites in human urine by gas chromatography/mass spectrometry after simultaneous use of cocaine and alcohol. J Pharm Biomed Anal 1995;13:305-12.
4. Grant JM. The fetal heart rate trace is normal, isn't it? Observer agreement of categorical assessments. Lancet 1991;337: 215-8.
5. San L, Tato J, Torrens M, Castillo M, Farré M, Camí J. Flunitraz epam consumption among heroin addicts admitted for in-patient detoxification. Drug Alcohol Depend 1993;32:281-6.
6. San L, Tato J, Torrens M, Castillo M, Porta M, de la Torre R Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990. Addiction 1993;88:1341-9.
7. Beck O, Lafolie P, Odelius G, Boreus LO. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol Lett 1990;52:7-14.
8. Beck O, Lafolie P, Hjemdhal P, Borg S, Odelius G, Wirbing P. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Clin Chem 1992;38:271-5.
9. Koch TR, Raglin RL, Kirk S, Bruni JF. Improved screening for benzodiazepine metabolites in urine using the Triage® Panel for Drugs of Abuse. J Anal Toxicol 1994;18:168-72.
10. Fitzgerald RL, Rexin DA, Herold DA. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem 1994;40:373-80.